iShares 20+ Year Treasury Bond ETF logo

iShares 20+ Year Treasury Bond ETF (TLT)

Market Open
21 Jul, 16:03
NASDAQ (NMS) NASDAQ (NMS)
$
83. 66
-0.23
-0.2801%
$
41.94B Market Cap
3.85% Div Yield
5.77M Volume
$ 83.89
Previous Close
Add Transaction
Day Range
83.44 83.77
Year Range
82.77 92.19
Want to track TLT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TLT Broke Out And Should Continue Higher (Technical Analysis)

TLT Broke Out And Should Continue Higher (Technical Analysis)

TLT just broke out, reaching a higher high for 2024, driven by anticipated rate cuts and lower inflation, and should be expected to trend higher. Long-term Treasuries offer steady income, high credit ratings, and act as a hedge against equity downturns, especially amid global economic uncertainty. TLT's chart shows a rounded bottoming pattern, indicating strong potential for further gains, particularly with forthcoming rate cuts and potential market weakness.

Seekingalpha | 1 year ago
TLT: Positioned For Upside During Fed Rate Cuts And Recession Risks

TLT: Positioned For Upside During Fed Rate Cuts And Recession Risks

Historical Fed rate pivots often precede recessions, highlighting deeper economic issues and potential downturns following interest rate cuts. Sharp declines in insider buying and job openings, coupled with rising consumer credit card delinquencies, signal significant economic stress and potential recession risks.

Seekingalpha | 1 year ago
Ruvidar(TM) Proven More Effective Than Acyclovir in Destruction of Herpes Simplex Virus

Ruvidar(TM) Proven More Effective Than Acyclovir in Destruction of Herpes Simplex Virus

Theralase® Technologies Inc. is currently seeking partnerships / licensing opportunities in the commercial development of this latest discovery TORONTO, ON / ACCESSWIRE / September 3, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that it's lead drug formulation, Ruvidar TM , has been demonstrated preclinically to be more effective in the destruction of the Herpes Simplex Virus 1 ("HSV-1") than the currently approved standard of care drug, Acyclovir. Acyclovir is an antiviral drug used to slow the growth and spread of the HSV-1 virus in the body.

Accesswire | 1 year ago
ETF of the week: TLT waits for the Jackson Hole Symposium

ETF of the week: TLT waits for the Jackson Hole Symposium

The iShares 20+ Year Treasury Bond (TLT) ETF has crawled back in the past few months as concerns about the American economy have risen. The TLT ETF fund jumped to a high of $100 earlier this month, its highest point since May 2021.

Invezz | 1 year ago
TLT: Sahm Rule Triggered, Raising Recession Risk (Rating Upgrade)

TLT: Sahm Rule Triggered, Raising Recession Risk (Rating Upgrade)

TLT recently experienced a strong rally due to disappointing economic data and slower inflation, improving its negative correlation with the equity market. CPI YoY dropped below 3% for the first time since 2021, increasing expectations for Fed rate cuts and indicating that inflation is not capping TLT's upside potential. With the recent unemployment rate at 4.3% and the historically reliable Sahm Rule triggering a recession signal, the economy faces growing risks amid a still inverted yield curve.

Seekingalpha | 1 year ago
Bonds are back. Is it too late to chase the summer rally?

Bonds are back. Is it too late to chase the summer rally?

Government bonds are making a comeback in 2024 after a years-long bear market resulted in the longest stretch of price declines in recent memory.

Marketwatch | 1 year ago
Fund manager bets $2.7 billion on imminent recession

Fund manager bets $2.7 billion on imminent recession

For much of 2024, the stock market has been driven by two seemingly opposite forces: the exceptionally strong performance of the S&P 500 and the biggest, mostly tech companies, and by persistent recessionary fears driven by concerns over a possible artificial intelligence (AI) bubble, consistently high interest rates, and the ever-increasing indebtedness of the Federal Government.

Finbold | 1 year ago
The TLT ETF Looks Ready To Break Out

The TLT ETF Looks Ready To Break Out

Long-term Treasury bonds are gaining renewed interest due to potential rate cuts and lower inflation levels. Treasury bonds offer steady income, safety, and hedging capacity in a portfolio. Recent market conditions suggest Treasury bonds, including the iShares 20+ Year Treasury Bond ETF, may perform well in the coming months.

Seekingalpha | 1 year ago
TLT: This Changes Everything

TLT: This Changes Everything

The iShares 20+ Year Treasury Bond ETF had its best week in 2024, and is up over 7% in two weeks. The Fed's shift in focus to labor market followed by a very weak jobs report opens up the potential for aggressive rate cuts into 2025. TLT can be expected to challenge $100-100.5 area and $109 later this year.

Seekingalpha | 1 year ago
Bond funds raked in nearly $400 billion in the first half of 2024

Bond funds raked in nearly $400 billion in the first half of 2024

Investors have been pouring into bond funds this year as interest-rate cuts begin trickling out from global central banks.

Marketwatch | 2 years ago
TLT: Bonds Offer Favorable Odds Now

TLT: Bonds Offer Favorable Odds Now

TLT offers exposure to long-term U.S. Treasury bonds with extended duration. TLT provides a favorable return/risk profile under current conditions. The current inflation data and future contracts both point to lower rates.

Seekingalpha | 2 years ago
TLT: 4 Reasons To Remain Bullish

TLT: 4 Reasons To Remain Bullish

TLT may face near-term volatility due to inflation and economic data, but long-term trajectory could be impacted by treasuries issuance and demand. Inflation is slowing down, with the Fed conservatively projecting only one rate cut in 2024 if inflation continues trending towards 2%. Recent economic data shows potential weakening, with job numbers and consumer sentiment softening, which could benefit TLT in a hard landing scenario.

Seekingalpha | 2 years ago
Loading...
Load More